Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-01-13 @ 7:50 AM
Study NCT ID:
NCT03184558
Status:
TERMINATED
Last Update Posted:
2021-11-09
First Post:
2017-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC
Sponsor:
Organization: